Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01260701What this trial is testingAkt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Gastric AdenocarcinomaGastric Intestinal Type Adenocarcinoma+2 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT00005049What this trial is testingCombination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerWho this might be right forColorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more NYU Langone Health 45
Testing effectiveness (Phase 2)Study completedNCT00012363What this trial is testingS0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusWho this might be right forEsophageal CancerGastric Cancer SWOG Cancer Research Network 61
Testing effectiveness (Phase 2)Looking for participantsNCT03175224What this trial is testingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced CancerRenal Cancer+15 more Apollomics Inc. 497
Early research (Phase 1)Study completedNCT00635596What this trial is testingPhase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian CancerWho this might be right forSolid Tumors Amgen Research (Munich) GmbH 65
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Large-scale testing (Phase 3)Not Yet RecruitingNCT06870565What this trial is testingComparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type AdenocarcinomaWho this might be right forGastric-type Endocervical AdenocarcinomaCervical Cancer Women's Hospital School Of Medicine Zhejiang University 238
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03918499What this trial is testingIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction CancerWho this might be right forClinical Stage IV Gastric Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8+15 more City of Hope Medical Center 9
Testing effectiveness (Phase 2)UnknownNCT00985556What this trial is testingOxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerWho this might be right forGastric Cancer Yonsei University 130
Testing effectiveness (Phase 2)Study completedNCT00061932What this trial is testingBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT03196232What this trial is testingEpacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric CancerWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaRecurrent Esophageal Carcinoma+4 more George Albert Fisher 3
Testing effectiveness (Phase 2)Study completedNCT04164979What this trial is testingPh II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroEsophageal Cancer University of California, Irvine 34
Early research (Phase 1)Study completedNCT04074343What this trial is testingTAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroEsophageal Cancer University of California, Irvine 20
Not applicableUnknownNCT03278327What this trial is testingImpact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's OesophagusWho this might be right forBarrett Esophagus Adenocarcinoma Institut Paoli-Calmettes 30
Not applicableNot Yet RecruitingNCT07191405What this trial is testingClinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid TumorsWho this might be right forImmunotherapyChemotherapy Second Affiliated Hospital, Zhejiang University, School of Medicine 156
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Early research (Phase 1)WithdrawnNCT00017537What this trial is testingVaccine Therapy in Treating Patients With Metastatic or Recurrent CancerWho this might be right forBreast CancerGastric CancerLung Cancer+2 more University of Alabama at Birmingham